BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34413267)

  • 1. The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer.
    Jiang Y; Chen L; Shen J; Mei X; Yao J; Chen T; Zhou Y
    Aging (Albany NY); 2021 Aug; 13(17):20886-20895. PubMed ID: 34413267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
    Tang Q; Wang Y; Ou L; Li J; Zheng K; Zhan H; Gu J; Zhou G; Xie S; Zhang J; Huang W; Wang S; Wang X
    Int J Biol Sci; 2021; 17(8):1925-1939. PubMed ID: 34131396
    [No Abstract]   [Full Text] [Related]  

  • 3. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19.
    Yang W; Li L; Zhang K; Ma K; Xie H; Gong Y; Zhou J; Gong K
    Int J Biol Sci; 2021; 17(1):20-31. PubMed ID: 33390830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.
    Yang J; Li H; Hu S; Zhou Y
    Aging (Albany NY); 2020 Apr; 12(8):6518-6535. PubMed ID: 32339157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis.
    Nair MG; Prabhu JS; Ts S
    Cancer Treat Res Commun; 2021; 27():100321. PubMed ID: 33517235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
    Uddin MN; Akter R; Li M; Abdelrahman Z
    Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
    Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
    Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
    Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients.
    Gutiérrez-Chamorro L; Riveira-Muñoz E; Barrios C; Palau V; Nevot M; Pedreño-López S; Senserrich J; Massanella M; Clotet B; Cabrera C; Mitjà O; Crespo M; Pascual J; Riera M; Ballana E
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases.
    Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R
    Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
    Amendola A; Garoffolo G; Songia P; Nardacci R; Ferrari S; Bernava G; Canzano P; Myasoedova V; Colavita F; Castilletti C; Sberna G; Capobianchi MR; Piacentini M; Agrifoglio M; Colombo GI; Poggio P; Pesce M
    Cardiovasc Res; 2021 May; 117(6):1557-1566. PubMed ID: 33705542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
    Ling J; Peng N; Luo L
    J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
    Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
    Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.
    Huang X; He C; Hua X; Kan A; Sun S; Wang J; Li S
    Int J Biol Sci; 2020; 16(13):2464-2476. PubMed ID: 32760213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.
    Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M
    EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.